Skip to main content
. 2022 Aug 17;48:147. doi: 10.1186/s13052-022-01316-4

Table 1.

Epidemiological, auxological, clinical data, imaging, pathology, management and outcome of our cases

Sex/age
clinical onset (months)
Age at diagnosis (months) Auxological data Neurological pattern Clinical findings MRI features Pathology Chemo-therapy Surgery RT Outcome
percentile Z score
M/18 26

W

L

W/L

HC

3rd

10th

-

-1.7

-1.2

-1.4

Irritability

Hyperactivity

Normal exam

Ematiation

Sleeping

disorder

suprasellar lesion

(44 × 40x38 mm)

hypothalamic-pituitary

chiasmatic region,

hydrocephalus

Low-grade

astrocytoma

Carboplatin

etoposide

VP

derivation

no alive
F/8 14

W

L

W/L

HC

< 3rd

5th

75th

-1.9

-1.6

-1.6

Normal exam

Alert

Pale skin

emaciation

suprasellar lesion

(40 × 36x31 mm)

hypothalamic-pituitary

region, extended to 3rd

ventricle

Low-grade

astrocytoma

Carboplatin

etoposide

vinorelbin

Resection yes died
M/8 16

W

L

W/L

HC

10th

>> 97th

90th

-1.2

4.9

-5

Nistagmus

Hyperactivity

Normal exam

Pale skin

emaciation

Multilobate pseudocystic

suprasellar lesion

(47 × 38x39 mm)

hypothalamic-pituitary

and chiasmatic region

Pilomyxoid

astrocytoma

Carboplatin

Etoposide

bevacizumab

irinotecan

Debulking no alive

MRI Magnetic resonance imaging, M male, F Female, W Weight, L Length, W/L Weight/Length, HC Head circumference, VP Ventriculo-peritoneal, RT Radiotherapy